SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Privi Speciality Chemicals informs about outcome of board meeting

20 Dec 2025 Evaluate
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (the SEBI Listing Regulations), Privi Speciality Chemicals has informed that the Board of Directors of the Company at their meeting held on Friday, December 19, 2025, which commenced at 03:00 pm and concluded at 05:00 pm have considered and approved: The Scheme of Amalgamation of Privi Fine Sciences Private Limited, (PFSPL or Transferor Company 1) and Privi Biotechnologies Private Limited, a wholly owned subsidiary of the Company (PBPL or Transferor Company 2) (PFSPL together with PBPL, Transferor Companies), with Privi Speciality Chemicals Limited (PSCL or Transferee Company) and their respective shareholders (hereinafter referred to as scheme of Amalgamation) under Sections 230 to232of the Companies Act, 2013 and other applicable laws. The Scheme is subject to the approval of the shareholders, creditors, the Hon’ble National Company Law Tribunal (NCLT) and such other regulatory authorities, as maybe required, under the applicable law. The disclosure in respect to the aforesaid Scheme as required under Regulation 30 read with Schedule III, part A to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations) read with the SEBI Circular No SEBI/HO11FD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 is attached as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Privi Speciality Che Share Price

2936.70 39.05 (1.35%)
13-Apr-2026 12:49 View Price Chart
Peers
Company Name CMP
BASF India 3605.40
Tata Chemicals 724.85
SRF 2454.10
Pidilite Inds. 1331.90
Deepak Nitrite 1457.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×